Creative Medical Technology Holdings, Inc. (CELZ) vs Imunon, Inc. (IMNN)

Creative Medical Technology Holdings, Inc. and Imunon, Inc. are both Biotechnology companies. Imunon, Inc. is the larger, with a market value of $6.0M against $5.4M — 1.1× the size. Imunon, Inc. grew revenue faster over the last twelve months: 0.00% against −79.4%. Across the 15 metrics below, Creative Medical Technology Holdings, Inc. leads on 9 and Imunon, Inc. on 6.

Valuation

Metric CELZ IMNN Biotechnology median
P/E n/m n/m 8.50
P/S 161.13 10.67 9.71
P/B 0.32 2.76 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.98 n/m 0.64
EV/Sales (351.86) 8.01 9.21
Earnings yield (279.73%) (375.49%) (33.15%)
Free cash flow yield (409.71%) (284.77%) (25.50%)

Profitability

Metric CELZ IMNN Biotechnology median
Gross margin 61.18% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (77.91%) (641.02%) (56.36%)
Return on assets (73.30%) (123.93%) (48.04%)
Return on invested capital 0.00% (324.37%) 0.00%

Growth

Metric CELZ IMNN Biotechnology median
Revenue growth (TTM) (79.42%) 0.00% 6.02%
EPS growth (last fiscal year) 32.08% 67.66% 30.26%
Revenue growth, 5-year CAGR (48.43%) 0.00% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CELZ IMNN Biotechnology median
Debt to equity 0.00 1.32 0.00
Current ratio 12.91 1.82 4.72
Net debt to EBITDA 1.20 0.63 0.96

Dividend

Metric CELZ IMNN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CELZ IMNN Biotechnology median
Market cap 5.39m 5.95m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack